お見積

サンプルお申込み

お問い合わせ

今すぐ購入

※ご注文方法：お問い合わせフォームまたはメールにてご連絡ください。
支払方法：「銀行振込」の場合， 注文の確認後、ご指定のメールアドレスに電子版の請求書をお送りいたしますので、電子版の請求書の記載事項に従って送金操作を行ってください。
※納期：原則として、受注後2～4営業日以内に発送いたします。 但し、日本語版が必要な場合は、受注後8～10営業日となります。 お客様のニーズに合わせて、事前にご注文のスケジュールをお立てください。

本報告書はウイルスの不活性化市場規模の世界市場の概要を紹介します。2019~2023年の歴史的な市場収益データ、2024年の予想、および2030年までのCAGRの予測を含む世界市場動向の分析。レポートはウイルスの不活性化の主要メーカーを詳細に分析し、地域別・国別の収益プロフィールを明らかにしています。 本レポートでは特に、主要地域/国別のセグメントとサブセグメントについて、将来の市場ポテンシャルの探索と予測に焦点を当てています。 複数の地域にわたる包括的なデータと市場価値分析により、読者は包括的かつ詳細な市場洞察を得ることができます。

世界のウイルスの不活性化市場の主な参加者である企業概要、収益、粗利益率、ポートフォリオ、地理的位置、重要な発展について、次のパラメータに基づいて説明します。レポートはウイルスの不活性化のメーカー、地域、種類と端末業界の角度から世界と主要地域の市場現状と将来性を研究した、このレポートでは、世界と主要地域のトップメーカーを分析し、タイプとアプリケーション/端末業界別にウイルスの不活性化市場を分類しています。本研究に含まれる主な企業は：Danaher、Merck、Parker Hannifin、Sartorius、SGS、Charles River Laboratories International、Clean Cells、Rad Source Technologies、Texcell、Viral Inactivated Plasma Systems、Wuxi Pharmatech (Cayman)

地域別市場区分、地域別分析は以下の通り：
    アメリカとカナダ
    中国
    アジア
    ヨーロッパ
    中東、アフリカ、ラテンアメリカ

タイプ別市場セグメント：
    Kits and Reagents
    Services
    Viral Inactivation Systems and Accessories

用途別の市場セグメント：
    Blood and Blood Products
    Cellular and Gene Therapy Products
    Stem Cell Products
    Tissue and Tissue Products
    Vaccines and Therapeutics

本レポートの詳細内容
世界のウイルスの不活性化市場の現状と将来について、グローバルの主要地域を中心に包括的に分析しています。 当レポートでは、多角的な分析を通じて、市場プレイヤー、地域分布、ウイルスの不活性化タイプ、最終用途アプリケーションなどの主要分野を掘り下げ、読者に包括的な市場洞察を提供しています。 レポートは主要企業のウイルスの不活性化収益、市場シェア、業界ランキング、2019年から2024年までのデータに焦点を当てています。世界のウイルスの不活性化市場における主要なステークホルダーの特定、最近の動向とセグメント収益に基づいて競争状況と市場ポジショニングの分析。また、当レポートでは、世界市場の主要プレイヤーを特定し、プロファイルを作成するとともに、ウイルスの不活性化市場を綿密に分類・応用することで、読者が市場構造とダイナミクスをより正確に把握できるようにし、十分な情報に基づいた意思決定と戦略立案に強力なサポートを提供しています。

ウイルスの不活性化のレポートは2019年から2030年までのタイプ別およびアプリケーション別、収益、成長率別のセグメントデータを分析します。収益、予測成長傾向、アプリケーション、およびエンドユーザー業界の市場規模を評価および予測します。

章の概要
第1章：ウイルスの不活性化のレポートの報告範囲、各セグメントの市場規模、将来の開発可能性などを含む、さまざまな市場セグメント（製品タイプ、用途など）のエグゼクティブサマリーを紹介します。市場の現状と、短期から中期、および長期的な進化の可能性をハイレベルに見ることができます。（2019～2030）
第2章：ウイルスの不活性化の世界及び地域レベルでの売上高。各地域とその主要国の市場規模と発展の可能性を定量的に分析し、世界各国の市場発展、今後の発展展望、市場空間、生産能力などを紹介する。また、市場ダイナミクス、市場の最新動向、市場の推進要因と制限要因、業界企業が直面する課題とリスク、業界の関連政策の分析などを紹介しています。（2019～2030）
第3章ウイルスの不活性化企業の競争状況、収益、市場シェアと業界ランキング、最新の開発計画、合併・買収情報などの詳細分析。（2019～2030）
第4章：各市場セグメントの収益と開発の可能性をカバーし、種類別のさまざまな市場セグメントの分析を提供し、読者がさまざまな市場セグメントでブルーオーシャン市場を見つけるのに役立ちます。（2019～2024）
第5章：ウイルスの不活性化の各市場セグメントの収益と開発の可能性をカバーするアプリケーション別のさまざまな市場セグメントの分析を提供し、読者がさまざまな下流市場でブルーオーシャン市場を見つけるのに役立ちます。（2019～2030）
第6章：北米（米国、カナダ）のタイプ別、アプリケーション別、国別、各セグメントの収益。（2019～2030）
第7章：ヨーロッパのタイプ別、アプリケーション別、国別、各セグメントの収益。（2019～2030）
第8章：中国の種類別、および用途別、各セグメントの収益。（2019～2030）
第9章アジア（中国を除く）の種類別、用途別、地域別、セグメントごとの収益。（2019～2030）
第10章：中東、アフリカ、ラテンアメリカの種類別、アプリケーション別、国別、各セグメントの収益。（2019～2030）
第11章：ウイルスの不活性化の主要企業の概要を提供し、製品の説明と仕様、ウイルスの不活性化の収益、粗利益率、最近の展開など、市場の主要企業の基本状況を詳細に紹介します。（2019～2024）
第12章：アナリストの見解/結論

Viral inactivation is important and mandatory step in the manufacturing process of biological products to remove or inactivate potential contaminant viruses. These biological products are used for the treatment and diagnostic purposes in humans.
Market Analysis and Insights: Global Viral Inactivation Market
The global Viral Inactivation market is projected to grow from US$ 556.6 million in 2024 to US$ 989.3 million by 2030, at a Compound Annual Growth Rate (CAGR) of 10.1% during the forecast period.
Estimates of their viral inactivation market segment revenues were validated through primary interviews. Primary interviews with key opinion leaders were also used to determine the percentage shares of each subsegment and the relative differences in growth rates.
Report Covers:
This report presents an overview of global market for Viral Inactivation market size. Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030. 
This report researches the key producers of Viral Inactivation, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Viral Inactivation, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Viral Inactivation revenue, market share and industry ranking of main companies, data from 2019 to 2024. Identification of the major stakeholders in the global Viral Inactivation market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2019 to 2030. Evaluation and forecast the market size for Viral Inactivation revenue, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Danaher, Merck, Parker Hannifin, Sartorius, SGS, Charles River Laboratories International, Clean Cells, Rad Source Technologies and Texcell, etc.

Market Segmentation
By Company
    Danaher
    Merck
    Parker Hannifin
    Sartorius
    SGS
    Charles River Laboratories International
    Clean Cells
    Rad Source Technologies
    Texcell
    Viral Inactivated Plasma Systems
    Wuxi Pharmatech (Cayman)

Segment by Type
    Kits and Reagents
    Services
    Viral Inactivation Systems and Accessories

Segment by Application
    Blood and Blood Products
    Cellular and Gene Therapy Products
    Stem Cell Products
    Tissue and Tissue Products
    Vaccines and Therapeutics

By Region
    North America
        United States
        Canada
    Europe
        Germany
        France
        UK
        Italy
        Russia
        Nordic Countries
        Rest of Europe
    China
    Asia (excluding China)
        Japan
        South Korea
        China Taiwan
       Southeast Asia
        India
    Latin America, Middle East & Africa
        Brazil
        Mexico
        Turkey
        Israel
        GCC Countries

Chapter Outline
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of Viral Inactivation in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Viral Inactivation companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, revenue for each segment.
Chapter 8: China by Type, and by Application, revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Viral Inactivation revenue, gross margin, and recent development, etc.
Chapter 12: Analyst's Viewpoints/Conclusions

List of Tables
    Table 1. Global Viral Inactivation Market Size Growth Rate by Type (US$ Million), 2019 VS 2023 VS 2030
    Table 2. Key Players of Kits and Reagents
    Table 3. Key Players of Services
    Table 4. Key Players of Viral Inactivation Systems and Accessories
    Table 5. Global Viral Inactivation Market Size Growth Rate by Application (US$ Million), 2019 VS 2023 VS 2030
    Table 6. Global Viral Inactivation Market Size Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 7. Global Viral Inactivation Market Size by Region (2019-2024) & (US$ Million)
    Table 8. Global Viral Inactivation Market Share by Region (2019-2024)
    Table 9. Global Viral Inactivation Forecasted Market Size by Region (2025-2030) & (US$ Million)
    Table 10. Global Viral Inactivation Market Share by Region (2025-2030)
    Table 11. Viral Inactivation Market Trends
    Table 12. Viral Inactivation Market Drivers
    Table 13. Viral Inactivation Market Challenges
    Table 14. Viral Inactivation Market Restraints
    Table 15. Global Viral Inactivation Revenue by Players (2019-2024) & (US$ Million)
    Table 16. Global Viral Inactivation Revenue Share by Players (2019-2024)
    Table 17. Global Top Viral Inactivation by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Viral Inactivation as of 2023)
    Table 18. Global Viral Inactivation Industry Ranking 2022 VS 2023 VS 2024
    Table 19. Global 5 Largest Players Market Share by Viral Inactivation Revenue (CR5 and HHI) & (2019-2024)
    Table 20. Global Key Players of Viral Inactivation, Headquarters and Area Served
    Table 21. Global Key Players of Viral Inactivation, Product and Application
    Table 22. Global Key Players of Viral Inactivation, Product and Application
    Table 23. Mergers & Acquisitions, Expansion Plans
    Table 24. Global Viral Inactivation Market Size by Type (2019-2024) & (US$ Million)
    Table 25. Global Viral Inactivation Revenue Market Share by Type (2019-2024)
    Table 26. Global Viral Inactivation Forecasted Market Size by Type (2025-2030) & (US$ Million)
    Table 27. Global Viral Inactivation Revenue Market Share by Type (2025-2030)
    Table 28. Global Viral Inactivation Market Size by Application (2019-2024) & (US$ Million)
    Table 29. Global Viral Inactivation Revenue Share by Application (2019-2024)
    Table 30. Global Viral Inactivation Forecasted Market Size by Application (2025-2030) & (US$ Million)
    Table 31. Global Viral Inactivation Revenue Share by Application (2025-2030)
    Table 32. North America Viral Inactivation Market Size by Type (2019-2024) & (US$ Million)
    Table 33. North America Viral Inactivation Market Size by Type (2025-2030) & (US$ Million)
    Table 34. North America Viral Inactivation Market Size by Application (2019-2024) & (US$ Million)
    Table 35. North America Viral Inactivation Market Size by Application (2025-2030) & (US$ Million)
    Table 36. North America Viral Inactivation Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 37. North America Viral Inactivation Market Size by Country (2019-2024) & (US$ Million)
    Table 38. North America Viral Inactivation Market Size by Country (2025-2030) & (US$ Million)
    Table 39. Europe Viral Inactivation Market Size by Type (2019-2024) & (US$ Million)
    Table 40. Europe Viral Inactivation Market Size by Type (2025-2030) & (US$ Million)
    Table 41. Europe Viral Inactivation Market Size by Application (2019-2024) & (US$ Million)
    Table 42. Europe Viral Inactivation Market Size by Application (2025-2030) & (US$ Million)
    Table 43. Europe Viral Inactivation Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 44. Europe Viral Inactivation Market Size by Country (2019-2024) & (US$ Million)
    Table 45. Europe Viral Inactivation Market Size by Country (2025-2030) & (US$ Million)
    Table 46. China Viral Inactivation Market Size by Type (2019-2024) & (US$ Million)
    Table 47. China Viral Inactivation Market Size by Type (2025-2030) & (US$ Million)
    Table 48. China Viral Inactivation Market Size by Application (2019-2024) & (US$ Million)
    Table 49. China Viral Inactivation Market Size by Application (2025-2030) & (US$ Million)
    Table 50. Asia Viral Inactivation Market Size by Type (2019-2024) & (US$ Million)
    Table 51. Asia Viral Inactivation Market Size by Type (2025-2030) & (US$ Million)
    Table 52. Asia Viral Inactivation Market Size by Application (2019-2024) & (US$ Million)
    Table 53. Asia Viral Inactivation Market Size by Application (2025-2030) & (US$ Million)
    Table 54. Asia Viral Inactivation Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 55. Asia Viral Inactivation Market Size by Region (2019-2024) & (US$ Million)
    Table 56. Asia Viral Inactivation Market Size by Region (2025-2030) & (US$ Million)
    Table 57. Middle East, Africa, and Latin America Viral Inactivation Market Size by Type (2019-2024) & (US$ Million)
    Table 58. Middle East, Africa, and Latin America Viral Inactivation Market Size by Type (2025-2030) & (US$ Million)
    Table 59. Middle East, Africa, and Latin America Viral Inactivation Market Size by Application (2019-2024) & (US$ Million)
    Table 60. Middle East, Africa, and Latin America Viral Inactivation Market Size by Application (2025-2030) & (US$ Million)
    Table 61. Middle East, Africa, and Latin America Viral Inactivation Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 62. Middle East, Africa, and Latin America Viral Inactivation Market Size by Country (2019-2024) & (US$ Million)
    Table 63. Middle East, Africa, and Latin America Viral Inactivation Market Size by Country (2025-2030) & (US$ Million)
    Table 64. Danaher Company Details
    Table 65. Danaher Business Overview
    Table 66. Danaher Viral Inactivation Product
    Table 67. Danaher Revenue in Viral Inactivation Business (2019-2024) & (US$ Million)
    Table 68. Danaher Recent Developments
    Table 69. Merck Company Details
    Table 70. Merck Business Overview
    Table 71. Merck Viral Inactivation Product
    Table 72. Merck Revenue in Viral Inactivation Business (2019-2024) & (US$ Million)
    Table 73. Merck Recent Developments
    Table 74. Parker Hannifin Company Details
    Table 75. Parker Hannifin Business Overview
    Table 76. Parker Hannifin Viral Inactivation Product
    Table 77. Parker Hannifin Revenue in Viral Inactivation Business (2019-2024) & (US$ Million)
    Table 78. Parker Hannifin Recent Developments
    Table 79. Sartorius Company Details
    Table 80. Sartorius Business Overview
    Table 81. Sartorius Viral Inactivation Product
    Table 82. Sartorius Revenue in Viral Inactivation Business (2019-2024) & (US$ Million)
    Table 83. Sartorius Recent Developments
    Table 84. SGS Company Details
    Table 85. SGS Business Overview
    Table 86. SGS Viral Inactivation Product
    Table 87. SGS Revenue in Viral Inactivation Business (2019-2024) & (US$ Million)
    Table 88. SGS Recent Developments
    Table 89. Charles River Laboratories International Company Details
    Table 90. Charles River Laboratories International Business Overview
    Table 91. Charles River Laboratories International Viral Inactivation Product
    Table 92. Charles River Laboratories International Revenue in Viral Inactivation Business (2019-2024) & (US$ Million)
    Table 93. Charles River Laboratories International Recent Developments
    Table 94. Clean Cells Company Details
    Table 95. Clean Cells Business Overview
    Table 96. Clean Cells Viral Inactivation Product
    Table 97. Clean Cells Revenue in Viral Inactivation Business (2019-2024) & (US$ Million)
    Table 98. Clean Cells Recent Developments
    Table 99. Rad Source Technologies Company Details
    Table 100. Rad Source Technologies Business Overview
    Table 101. Rad Source Technologies Viral Inactivation Product
    Table 102. Rad Source Technologies Revenue in Viral Inactivation Business (2019-2024) & (US$ Million)
    Table 103. Rad Source Technologies Recent Developments
    Table 104. Texcell Company Details
    Table 105. Texcell Business Overview
    Table 106. Texcell Viral Inactivation Product
    Table 107. Texcell Revenue in Viral Inactivation Business (2019-2024) & (US$ Million)
    Table 108. Texcell Recent Developments
    Table 109. Viral Inactivated Plasma Systems Company Details
    Table 110. Viral Inactivated Plasma Systems Business Overview
    Table 111. Viral Inactivated Plasma Systems Viral Inactivation Product
    Table 112. Viral Inactivated Plasma Systems Revenue in Viral Inactivation Business (2019-2024) & (US$ Million)
    Table 113. Viral Inactivated Plasma Systems Recent Developments
    Table 114. Wuxi Pharmatech (Cayman) Company Details
    Table 115. Wuxi Pharmatech (Cayman) Business Overview
    Table 116. Wuxi Pharmatech (Cayman) Viral Inactivation Product
    Table 117. Wuxi Pharmatech (Cayman) Revenue in Viral Inactivation Business (2019-2024) & (US$ Million)
    Table 118. Wuxi Pharmatech (Cayman) Recent Developments
    Table 119. Research Programs/Design for This Report
    Table 120. Key Data Information from Secondary Sources
    Table 121. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Viral Inactivation Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 2. Global Viral Inactivation Market Share by Type: 2023 VS 2030
    Figure 3. Kits and Reagents Features
    Figure 4. Services Features
    Figure 5. Viral Inactivation Systems and Accessories Features
    Figure 6. Global Viral Inactivation Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 7. Global Viral Inactivation Market Share by Application: 2023 VS 2030
    Figure 8. Blood and Blood Products Case Studies
    Figure 9. Cellular and Gene Therapy Products Case Studies
    Figure 10. Stem Cell Products Case Studies
    Figure 11. Tissue and Tissue Products Case Studies
    Figure 12. Vaccines and Therapeutics Case Studies
    Figure 13. Viral Inactivation Report Years Considered
    Figure 14. Global Viral Inactivation Market Size (US$ Million), Year-over-Year: 2019-2030
    Figure 15. Global Viral Inactivation Market Size, (US$ Million), 2019 VS 2023 VS 2030
    Figure 16. Global Viral Inactivation Market Share by Region: 2023 VS 2030
    Figure 17. Global Viral Inactivation Market Share by Players in 2023
    Figure 18. Global Top Viral Inactivation Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Viral Inactivation as of 2023)
    Figure 19. The Top 10 and 5 Players Market Share by Viral Inactivation Revenue in 2023
    Figure 20. North America Viral Inactivation Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 21. North America Viral Inactivation Market Share by Type (2019-2030)
    Figure 22. North America Viral Inactivation Market Share by Application (2019-2030)
    Figure 23. North America Viral Inactivation Market Share by Country (2019-2030)
    Figure 24. United States Viral Inactivation Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 25. Canada Viral Inactivation Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 26. Europe Viral Inactivation Market Size YoY (2019-2030) & (US$ Million)
    Figure 27. Europe Viral Inactivation Market Share by Type (2019-2030)
    Figure 28. Europe Viral Inactivation Market Share by Application (2019-2030)
    Figure 29. Europe Viral Inactivation Market Share by Country (2019-2030)
    Figure 30. Germany Viral Inactivation Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 31. France Viral Inactivation Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 32. U.K. Viral Inactivation Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 33. Italy Viral Inactivation Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 34. Russia Viral Inactivation Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 35. Nordic Countries Viral Inactivation Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 36. China Viral Inactivation Market Size YoY (2019-2030) & (US$ Million)
    Figure 37. China Viral Inactivation Market Share by Type (2019-2030)
    Figure 38. China Viral Inactivation Market Share by Application (2019-2030)
    Figure 39. Asia Viral Inactivation Market Size YoY (2019-2030) & (US$ Million)
    Figure 40. Asia Viral Inactivation Market Share by Type (2019-2030)
    Figure 41. Asia Viral Inactivation Market Share by Application (2019-2030)
    Figure 42. Asia Viral Inactivation Market Share by Region (2019-2030)
    Figure 43. Japan Viral Inactivation Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 44. South Korea Viral Inactivation Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 45. China Taiwan Viral Inactivation Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 46. Southeast Asia Viral Inactivation Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 47. India Viral Inactivation Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 48. Australia Viral Inactivation Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 49. Middle East, Africa, and Latin America Viral Inactivation Market Size YoY (2019-2030) & (US$ Million)
    Figure 50. Middle East, Africa, and Latin America Viral Inactivation Market Share by Type (2019-2030)
    Figure 51. Middle East, Africa, and Latin America Viral Inactivation Market Share by Application (2019-2030)
    Figure 52. Middle East, Africa, and Latin America Viral Inactivation Market Share by Country (2019-2030)
    Figure 53. Brazil Viral Inactivation Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 54. Mexico Viral Inactivation Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 55. Turkey Viral Inactivation Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 56. Saudi Arabia Viral Inactivation Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 57. Israel Viral Inactivation Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 58. GCC Countries Viral Inactivation Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 59. Danaher Revenue Growth Rate in Viral Inactivation Business (2019-2024)
    Figure 60. Merck Revenue Growth Rate in Viral Inactivation Business (2019-2024)
    Figure 61. Parker Hannifin Revenue Growth Rate in Viral Inactivation Business (2019-2024)
    Figure 62. Sartorius Revenue Growth Rate in Viral Inactivation Business (2019-2024)
    Figure 63. SGS Revenue Growth Rate in Viral Inactivation Business (2019-2024)
    Figure 64. Charles River Laboratories International Revenue Growth Rate in Viral Inactivation Business (2019-2024)
    Figure 65. Clean Cells Revenue Growth Rate in Viral Inactivation Business (2019-2024)
    Figure 66. Rad Source Technologies Revenue Growth Rate in Viral Inactivation Business (2019-2024)
    Figure 67. Texcell Revenue Growth Rate in Viral Inactivation Business (2019-2024)
    Figure 68. Viral Inactivated Plasma Systems Revenue Growth Rate in Viral Inactivation Business (2019-2024)
    Figure 69. Wuxi Pharmatech (Cayman) Revenue Growth Rate in Viral Inactivation Business (2019-2024)
    Figure 70. Bottom-up and Top-down Approaches for This Report
    Figure 71. Data Triangulation
    Figure 72. Key Executives Interviewed